Laurus Labs Limited

NSE:LAURUSLABS.NS

470.4 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 11,949.114,396.711,949.212,244.511,817.913,80915,448.215,758.915,389.413,77810,287.612,034.812,78513,216.412,884.211,388.49,743.27,660.37,295.897,124.235,505.75,833.595,294.575,882.815,390.175,602.44,789.315,386.14,783.894,727.515,056.45,164.964,097.6
Cost of Revenue 8,168.99,853.75,454.15,810.85,839.26,945.87,193.87,074.16,529.57,378.14,240.25,326.75,538.26,669.45,830.85,012.94,460.64,489.293,605.553,599.862,745.63,682.152,839.423,146.392,951.482,909.162,457.532,813.462,456.92,205.812,808.182,826.922,126.74
Gross Profit 3,780.24,5436,495.16,433.75,978.76,863.28,254.48,684.88,859.96,399.96,047.46,708.17,246.86,5477,053.46,375.55,282.63,171.013,690.343,524.372,760.12,151.442,455.152,736.422,438.692,693.242,331.782,572.642,326.992,521.72,248.222,338.041,970.86
Gross Profit Ratio 0.3160.3160.5440.5250.5060.4970.5340.5510.5760.4650.5880.5570.5670.4950.5470.560.5420.4140.5060.4950.5010.3690.4640.4650.4520.4810.4870.4780.4860.5330.4450.4530.481
Reseach & Development Expenses 640690670580470315.9550490490294.7570420490172.9000151.8000131.5100000000000
General & Administrative Expenses 03,043.80002,183.20001,316.90001,158.4000924.08000824.78000745.44000682.87000
Selling & Marketing Expenses 0106.80001660004.900018.900062.700060.1700045.0300050.28000
SG&A 2,488.83,150.62,461.32,335.71,599.32,349.22,195.22,235.81,520.31,321.81,219.91,228.71,530.41,177.31,006.11,081.11,115.6986.78884.42879.54803.36884.95689734.75728.12790.47647.25633.72627.19733.15549.04535.32531.31
Other Expenses 25.1185.324.317.83617.114.311.117.5-131.453.328.358.5-150.469.351.270.9-31.419.2413.6145-87.3614.15105.2825.8750.8199.4466.2675.42102.01129.6689.1523.15
Operating Expenses 3,128.83,150.65,6655,488.75,2174,877.95,063.15,014.15,026.13,073.33,834.73,889.23,878.72,349.93,306.83,146.82,987.41,658.72,684.132,624.92,385.91,253.852,005.082,377.342,015.091,870.531,768.051,747.691,659.711,652.971,529.161,511.671,368.49
Operating Income 651.41,392.4854.4962.8797.72,002.43,205.63,681.83,851.33,350.92,212.72,818.93,368.14,197.13,746.63,228.72,295.21,512.311,006.21899.47374.2897.59450.07359.08423.6822.71563.73824.95667.28868.73719.06826.37602.37
Operating Income Ratio 0.0550.0970.0720.0790.0670.1450.2080.2340.250.2430.2150.2340.2630.3180.2910.2840.2360.1970.1380.1260.0680.1540.0850.0610.0790.1470.1180.1530.1390.1840.1420.160.147
Total Other Income Expenses Net -466.8-319.7-508.2-423.9-408-531-427.1-401.1-295.6-335.6-177.9-193-207.6-185.4-105-85.6-80.5-244.92-189.09-241.75-180.3-371.9-222.39-141.17-197.36-181.83-78.19-128.95-115.54-62.51-178.52-167.65-255.9
Income Before Tax 184.61,072.7346.2538.9405.81,471.42,778.53,280.73,558.83,017.12,0352,625.93,160.54,011.73,641.63,143.12,214.71,267.39817.12657.72193.9525.69227.68217.91226.24640.88485.54696551.74806.22540.54658.72346.47
Income Before Tax Ratio 0.0150.0750.0290.0440.0340.1070.180.2080.2310.2190.1980.2180.2470.3040.2830.2760.2270.1650.1120.0920.0350.090.0430.0370.0420.1140.1010.1290.1150.1710.1070.1280.085
Income Tax Expense 62.5319.594.5145.7121.8399747.9942.71,033.4698.1485.3586.4744.41,042.5913.1720.4496.9165.8982.3792.1942.993.949.5155.8160.66190.08136.84208.45162.6992.8994.72171.4479.59
Net Income 125.1756.1231.4369.5248.51,029.82,030.42,328.12,512.82,270.11,549.52,0192,413.92,966.82,728.52,422.71,717.81,101.5734.75565.53151431.79178.17162.1165.58450.8348.7487.55389.05713.33450.19482.81256.43
Net Income Ratio 0.010.0530.0190.030.0210.0750.1310.1480.1630.1650.1510.1680.1890.2240.2120.2130.1760.1440.1010.0790.0270.0740.0340.0280.0310.080.0730.0910.0810.1510.0890.0930.063
EPS 0.231.40.430.690.461.913.774.334.684.222.873.764.55.545.094.533.212.061.381.060.280.810.330.310.310.850.660.920.741.350.91.040.75
EPS Diluted 0.231.40.430.680.461.913.764.324.664.212.853.744.485.545.074.53.212.061.381.060.280.810.330.310.310.850.660.920.731.350.90.980.52
EBITDA 1,7122,414.91,838.51,896.51,703.22,872.54,0504,500.24,559.23,713.72,906.23,479.14,0124,646.74,332.33,789.92,854.11,772.481,500.951,391.98877.6996.5891.3862.54831.41,219.65972.921,192.011,040.551,252.681,123.081,161.88873.09
EBITDA Ratio 0.1430.1680.1540.1550.1440.2080.2620.2860.2960.270.2820.2890.3140.3520.3360.3330.2930.2310.2060.1950.1590.1710.1680.1470.1540.2180.2030.2210.2180.2650.2220.2250.213